1Semana·

And as promised, the 2.

Then I decided on $GDRX . This is a drug platform on which Americans can obtain medicines more cheaply. In view of the US administration's efforts to reduce drug prices, I think this is a promising opportunity for the future. Incidentally, one of the first partners to market their products via the platform is the very popular $NOVO B (+0,23 %)

A small addition: the title is not yet tradable in Germany.

27.08

GoodRx Hldg

Comprado a 4,30 US$

4 Comentarios

Klein-Anleger1@Klein-Anleger1

1Semana

Looks exciting, but the chart looks so horrible 😜

•

Chris@Multibagger

1Semana

@Klein-Anleger1 That is part of my investment philosophy. I don't give a damn about the chart when I buy shares with doubling or more potential. I don't even look at it. The chart is the past. I trade and assess future opportunities. You can like that and think it makes sense or not.
It works for me because I have no problem correcting a misjudgment and selling the stock. I don't let a 50% loss accumulate on shares in the hope that they will be back at +/- 0 after 100%.

•

Kurt N.@Revy

1Semana

@Multibagger interesting, when do you personally expect positive signals in the market that are reflected in the price?
In this case, do you work with a stop loss?

•

Chris@Multibagger

1Semana

@Revy I normally give such values 3-6 months (2 quarterly reports) so that I can assess whether I am right. And I don't set an SL. What should I use as a guide for such values? If they have not developed in the right direction after 6 months and there is no progress in the outlook either, I sell the share. If there is really bad news beforehand and a drop of 20%, I sell it immediately. If they are dragged down by a general downturn without there being any change in the prospects for success, I buy more.

•